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 Mutations in the Crumbs homolog 1 (CRB1) gene cause
severe retinal dystrophies. CRB1 mutations have been found
in patients with retinitis pigmentosa (RP) type 12 [1-3], an
early onset form of autosomal recessive RP characterized by
a preserved para-arteriolar retinal pigment epithelium
(PPRPE). CRB1 mutations have also been detected in patients
with early onset RP without PPRPE but with other RP12 char-
acteristics [2,4], and in RP patients who had developed Coats-
like exudative vasculopathy, a relatively rare complication of
RP characterized by vascular abnormalities, yellow extravas-
cular lipid depositions, and in severe cases retinal detachment
[5]. In addition, mutations in the CRB1 gene have been de-
tected in 10-13% of patients with Leber congenital amaurosis
(LCA), the most severe retinal dystrophy leading to blindness
or severe visual impairment in the first year of life [5-7].
CRB1 is homologous to the Drosophila transmembrane
protein Crumbs [1]. Crumbs is a key regulator of epithelial
apical-basal polarity in Drosophila [8,9], and is essential for
the correct formation of the photoreceptors [10,11]. Crumbs
is a central component of a molecular scaffold that controls
assembly of the zonula adherens. Crumbs and CRB1 localize
to corresponding subdomains of the photoreceptor apical
plasma membrane: the stalk of Drosophila photoreceptors and
the inner segment of mammalian photoreceptors, respectively
[10].
Database searches with the 37 amino acid cytoplasmic
domain of Drosophila Crumbs revealed two other human ho-
mologs [12]. The characterization of the Crumbs homolog 3
(CRB3) gene on 19p13.3 was recently described [13]. Here,
we report the characterization of the Crumbs homolog 2
(CRB2) gene, located on chromosome 9q33.3. We demonstrate
that CRB2 is predominantly expressed in retina, brain, and
kidney. Several examples of homologous genes that are im-
plicated in similar diseases have been described in the litera-
ture, such as fibrillin-1 and -2 in microfibrillopathies [14], and
fibulin-5 and -6 in age related macular degeneration [15,16].
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Purpose: Mutations in the Crumbs homolog 1 (CRB1) gene cause autosomal recessive retinitis pigmentosa (RP) and
Leber congenital amaurosis (LCA). Database searches reveal two other Crumbs homologs on chromosomes 9q33.3 and
19p13.3. The purpose of this study was to characterize the Crumbs homolog 2 (CRB2) gene on 9q33.3, to analyze its
expression pattern, and to determine whether mutations in CRB2 are associated with RP and LCA.
Methods: The CRB2 mRNA and its expression pattern in human tissues were analyzed by reverse transcription-poly-
merase chain reaction (RT-PCR). The cellular expression of Crb2 in the mouse eye was determined by mRNA in situ
hybridizations. The open reading frame and splice junctions of CRB2 were analyzed for mutations by single-strand con-
formation analysis and direct nucleotide sequencing in 85 RP patients and 79 LCA patients.
Results: The CRB2 gene consists of 13 exons and encodes a 1285 amino acid transmembrane protein. CRB2 is mainly
expressed in retina, brain, and kidney. In mouse retina Crb2 expression was detected in all cell layers. Mutation analysis
of the CRB2 gene revealed 11 sequence variants leading to an amino acid substitution. Three of them were not identified
in control individuals and affect conserved amino acid residues. However, the patients that carry these sequence variants
do not have a second sequence variant on the other allele, excluding autosomal recessive inheritance of CRB2 sequence
variants as a cause of their disease.
Conclusions: This study shows that CRB2 sequence variants are not a common cause of autosomal recessive RP and
LCA. It is possible that a more complex clinical phenotype is associated with the loss or altered function of CRB2 in
humans due to its expression in tissues other than the retina.
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In view of its homology to CRB1 and its expression in the
retina, we considered CRB2 to be a candidate gene for retinal
dystrophies and searched for CRB2 gene mutations in 85 RP
patients and 79 LCA patients.
METHODS
Bioinformatics:  Protein and translated nucleic acid sequence
databases were searched for Crumbs homologs with the C-
terminal 37 amino acids of Drosophila Crumbs and human
CRB1, using the BLAST programs [17]. The hits that were
generated were used in a BLAT search of the UCSC Human
Genome Working Draft [18] to obtain corresponding genomic
fragments and annotated gene predictions (FGenesH++,
Genscan, Twinscan, and GeneID). Deduced protein sequences
were searched for functional patterns using SMART [19] and
RPSBLAST [17], and by comparison to the CRB1 and Crumbs
domain structures. Multiple sequence alignments were cre-
ated using ClustalW [20] and boxed with BoxShade 3.21.
Reverse transcription (RT)-PCR analysis:  To verify the
CRB2 gene prediction, four overlapping nested primer sets
were designed from the predicted sequence and used for RT-
PCR on human retina cDNA (Table 1). The primary PCR re-
actions were performed on 2.5 µl human retina Marathon-
Ready cDNA (Clontech, Palo Alto, CA) with the GC-rich PCR
System (Roche, Almere, Netherlands) according to the
manufacturer’s recommendations. Primary PCR products were
purified (Qiaquick Gel Extraction Kit, Qiagen, Venlo, Neth-
erlands), diluted 100x, and used as a template for the nested
PCR reactions, using the GC-rich PCR System.
For expression profile analysis of the CRB2 gene, total
RNA samples from seven human tissues (brain, liver, lung,
skeletal muscle, placenta, heart, and kidney) were purchased
from Clontech. Total RNA from retina, fetal eye, RPE/chor-
oid, and RPE cell line ARPE-19 [21] was isolated using
RNAzolB (Campro Scientific, Veenendaal, Netherlands). To-
tal fetal cochlea RNA was isolated by CsCl purification [22].
Total RNA samples were treated with DNase I (Invitrogen,
Breda, Netherlands). Randomly primed cDNA synthesis and
RT-PCR were performed as described previously [23]. Table
2 shows primers used to determine the expression profile for
CRB1, CRB2, and GAPDH. Amplification was performed with
a touchdown PCR [24] at 94 °C for 1 min, T
ann
 for 1 min, 72
°C for 1 min using annealing temperatures (T
ann
) of 59 °C for
2 cycles, 58 °C for 2 cycles, 57 °C for 2 cycles, 56 °C for 2
cycles, and 55 °C for 24 cycles.
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TABLE 1. PCR PRIMERS FOR VERIFICATION OF THE CRB2 GENE PREDICTION
Fragment    Exon        Forward primer (5'>3')             Reverse primer (5'>3')
---------   -----   -------------------------------   --------------------------------
1 primary    1> 7   CTCCCGTTCTCACAGCAGCCGA            CACAGGACCAGAGGCCACACAGAGC
1 nested     1> 7   GGGCTGCCATGGCGCTGGCC              AGCTCCAAGCTTTCCTTGGTGTCATTGCGAG
2 primary    7> 8   ACTGAGGTTTCGCACCACACTGCC          CCACCCCAGGGCTGGCTGTC
2 nested     7> 8   GGAAAGCTTGGAGCTGGCATTGGTGGCAGC    CGGATCCGACCCTCACTCAGGAA
3 primary    7>10   AACGTCCTCCTGGGCTGTGAGC            ACGCGAAGTGCTCTCGGGCG
3 nested     8>10   TCCGCTGGCCTGTTGCTCCA              AGCAGGATGCGCACAGCACCCGGGCCCTGCAG
4 primary   10>13   CTGGCACCGCGTGCGTCTGG              GAAACCATTCAGGACCTCCAGGTGC
4 nested    10>13   TGTGCGCATCCTGCTGGCTGAGAACTTCACC   CCTAGATGAGTCTCTCCTCCGG
Four overlapping nested primer sets were designed from the CRB2 gene prediction and used for RT-PCR on human retina cDNA. Primary
PCR products were diluted and used as a template for the nested PCR reactions.
TABLE 2. PRIMERS USED TO DETERMINE THE EXPRESSION PROFILE FOR
CRB1, CRB2, AND GAPDH.
Gene     Exon       Sequence (5'>3')
-----    ----   ------------------------
CRB1      10    TGCAGACAGAGCAGATTACC
          11    AGCAAAGGCAACATCACAGAGG
CRB2      12    TCTGCAATGCCAGATTCTCCGG
          13    CGGTGGCACCTTGAGGACACTGTC
GAPDH      8    ACCACAGTCCATGCCATCAC
           9    TCCACCACCCTGTTGCTGTA
Expression profiles for CRB1, CRB2, and GAPDH were determined
by RT-PCR on RNA samples of eleven human tissues and RPE cell
line ARPE-19. To rule out genomic contamination, forward and re-
verse primers for each gene were designed in different exons.
TABLE 3. PCR PRIMERS FOR MUTATION ANALYSIS OF THE CRB2 GENE
Exon     Forward primer (5'>3')        Reverse primer (5'>3')
----   ---------------------------   --------------------------
 1     CTCCCGTTCTCACAGCAGCCGA        AGGCTTGGGGTATCTGTCTTGGGG
 2.1   ATTGTCCTTGTAACCTCTGCCCACCC    GAAACCCGGCACGCAGTAGCAG
 2.2   TGTGTGTGCCCCAGGGTCCAGA        ACACTCTGAGCAGCTGATGCGATCTG
 3.1   CTGCTCTGGGTGTCCATCCTGCAC      GGCTGGCTCTGGCACTCGTCGA
 3.2   TGGACGGCGTGGGCTCCTTC          GCACCGGCGGAGCTGAGCG
 4     AGGCGCGGGGCAGAAGGG            GCCGCACAGGCGCACACCTAC
 5     TAGTGAAGAGGTGCTGCCCGGCAA      TGGGCATCTGGACATGGGCTGA
 6     GCTATAGAATGGACCCTCTCAGCCCC    CACCTGAGGACCACCAATTCTGATGG
 7.1   GGTACTGAGGTCCCCATCATAAGAGGC   TGCACAGAACAGTCGCGCCCA
 7.2   ACGGCGGAACCTGCAGTGACAC        TCCCAGCCATCACAGAGAAGGTGG
 7.3   GGTCCACAGTTACGTCTGCCACTGC     TGCCACCAATGCCAGCTCCAAG
 7.4   ACTGAGGTTTCGCACCACACTGCC      CACAGGACCAGAGGCCACACAGAGC
 7.5   TTGTGCTCCATCTAGCGACCCTGG      TCACAGCCCAGGAGGACGTTCTCA
 7.6   TGGGGGACGCGACCTTTGCA          CAGATCTCAGGTGCTGCCTTCCCAC
 8.1   CAGCACCTGAGATCTGCCTCCCTCA     CGGATCCGACCCTCACTCAGGAA
 8.2   TCCGCTGGCCTGTTGCTCCA          CCACCCCAGGGCTGGCTGTC
 8.3   GACCTGGGGCAGCACGTGCA          AAAAGGACTCCCCACCCCACCAC
 9     AATGCCAGTTATGGTGGGTGATGCTC    AGCTTAGGTGTCCAGCACCCAGCA
10.1   GAAGTGGGGAGGTGGCATTTCTGGA     GCACCGCCAGCCACACGCC
10.2   CGAGGCCTGGCTGCTGCGTG          GGGTGGCGGCACCATCCAGC
10.3   CTGGCACCGCGTGCGTCTGG          ACGCGAAGTGCTCTCGGGCG
10.4   GAACTTCACCGGCTGCTTGGGC        AGGGGTCGACGTGGGCTTCG
10.5   GTGACCTCTTCGACGCCTTTGCC       GACTTCTCTGCCCCACCATAGCCC
11     AAGCTCAGGTGGCCCACGGTCA        TCATTGGACCTCCTCACAGTTCCCAG
12     CTGGGAGCACAAGAGGCAGCCA        ATCTCGCCAAGGGCCCAGCA
13.1   TGCTGCGCTCTCTGCTCTCTGAGG      GCTTGGGCTGTAGGTGCCCTCAGAC
13.2   CTGGGCCTCCTTTCAGGGATCCTG      GAAACCATTCAGGACCTCCAGGTGC
Twenty-seven primer pairs were designed for SSCA and sequence
analysis of the open reading frame and splice junctions of CRB2.
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In situ hybridizations:  A digoxigenin labeled antisense
riboprobe was transcribed from a mouse Crb2 cDNA clone
containing the last 1 kb of coding sequence and 2.5 kb of 3'
untranslated region. This clone was identified by sequencing
random clones from a custom made cDNA library of dissected
E9.5 mouse optic primorida (P. Rashbass, unpublished data).
Retinas from adult CBA mice were fixed overnight in 4%
paraformaldehyde, transferred to 30% sucrose in phosphate
buffered saline (PBS) prior to embedding in OCT, where they
were rapidly frozen on dry ice. 15 µm cryostat sections were
cut and air dried. Slides were hybridized overnight at 65 °C
with the diluted riboprobe in hybridization buffer (50%
formamide, 5% SSC pH 7.0, 0.5% CHAPS, 1 mg/ml yeast
RNA, 5 mM EGTA, 50 µg/ml heparin, 2% Roche blocking
reagent). They were then washed at 65 °C in 50% formamide,
5x SSC pH 4.5, 0.1% SDS followed by 2 washes of 50%
formamide, 2x SSC pH 4.5, 0.1% SDS. Following 3 washes
in Tris buffered saline Tween (TBST) they were blocked in
10% sheep serum in TBST and incubated in anti-digoxigenin-
AP conjugated Fab fragment (1:2000, Roche) overnight. Crb2
RNA localization was determined using NBT/BCIP detection
(Roche) of alkaline phosphatase. Once color had developed
sufficiently, the sections were refixed in 4% paraformalde-
hyde prior to imaging using DIC optics (Olympus BX60 mi-
croscope with Spot-TR color camera [Diagnostic Instruments.
Inc., Sterling Heights, MI] attached). Images were prepared
for publication using Adobe Photoshop.
Mutation analysis:  This study involved human subjects
and was approved by the institutional review board of the
Radboud Univerisity Nijmegen Medical Center. Mutation
analysis of the CRB2 gene was performed in 79 unrelated pa-
tients with autosomal recessive or isolated LCA, 81 unrelated
patients with autosomal recessive or isolated RP and 4 unre-
lated patients with autosomal dominant RP. Of the patients
with autosomal recessive or isolated RP, four presented with
PPRPE, six had developed Coats-like exudative vasculopathy,
and two were diagnosed with kidney disease (possible Senior-
Löken syndrome).
For mutation analysis of the open reading frame and splice
junctions of CRB2, 27 primer pairs were designed (Table 3).
Exons 2, 3, and 8.1-8.2 were screened for alterations by se-
quence analysis and the remaining amplicons by single-strand
conformation analysis (SSCA). In 10 patients, all amplicons
of the CRB2 gene were analyzed by sequencing. PCR reac-
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B:
Dm CRB    2110   RNKRATRGTYSPSAQEYCNPRLEMDNVLKPPPEERLI*   2146
Hs CRB1   1370   SNKRATQGTYSPSRQEKEGSRVEMWNLMPPPAMERLI*   1406
Hs CRB2   1249   RKRRQSEGTYSPSQQEVAGARLEMDSVLKVPPEERLI*   1285
Hs CRB3     84   REKRQTEGTYRPSSEEQVGARVPPTPNLKLPPEERLI*    120
Figure 1. Comparison of the CRB1, CRB2 and CRB3 proteins.  A: The protein domain structures of CRB1, CRB2, and CRB3. CRB1 and
CRB2 contain a large extracellular domain, a transmembrane domain, and a 37 amino acid cytoplasmic domain. CRB3 lacks the extracellular
domain, but has a cytoplasmic domain that is highly similar to CRB1 and CRB2. Amino acid substitutions found in the CRB2 gene in RP and
LCA patients are indicated by arrows. Numbering is based on GenBank entry AY720432. B: Alignment of the cytoplasmic domains of
Drosophila (Dm) Crumbs (CRB; M33753), human (Hs) CRB1 (AY043325), human (Hs) CRB2 (AY720432), and human (Hs) CRB3
(AY103469). Identical amino acids are indicated in red and conserved residues in blue. Each line lists the organism, protein name, N-terminal
amino acid position of the cytoplasmic domain, amino acid sequence of the cytoplasmic domain, and C-terminal amino acid position of the
cytoplasmic domain. Asterisks mark the stop codons.
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tions for SSCA were performed in a volume of 10 µl using 25
ng of genomic DNA and 2 pmol of each primer labeled with
0.2 pmol [γ-32P]ATP. PCR reactions for sequencing purposes
were performed in a volume of 25 µl using 100 ng of genomic
DNA and 10 pmol of each primer. PCR reactions contained
1.5 mM MgCl2, 0.2 mM of each dNTP, 0.5 U Taq DNA poly-
merase and PCR buffer provided by the manufacturer
(Invitrogen). For amplification of exons 3, 5, and 10, 1 M
DMSO was added to the reaction mixture. Amplification was
performed with a touchdown PCR at 94 °C for 20 s, T
ann
 for
20 s, 72 °C for 30 s using T
ann
 of 66 °C for 3 cycles, 64 °C for
3 cycles, 62 °C for 3 cycles, and 60 °C for 24 cycles (for SSCA)
or 30 cycles (for sequencing). PCR amplification was pre-
ceded by 3 min denaturing at 94 °C, and concluded with 3
min elongation at 72 °C. For SSCA, PCR products were de-
natured and electrophoresed on 8% polyacrylamide gels at 4
°C (10-12 W for 16 h). PCR products with altered electro-
phoretic mobility were analyzed by sequencing. For DNA se-
quencing, PCR products were purified with the StrataPrep 96
PCR Purification Kit (Stratagene, La Jolla, CA). Sequencing
was performed with BigDye Terminator chemistry (version
3) on a 3730 or 3100 DNA Analyzer (Applied Biosystems,
Foster City, CA).
Amino acid substitutions p.V97L and p.E187D were ana-
lyzed in control individuals with the amplification-refractory
mutation system (ARMS) [25,26]. For p.P46L and p.A351T
ARMS was unsuccessful, while diagnostic restriction sites
were not available. The remaining amino acid substitutions
were tested in control individuals by PCR amplification and
restriction enzyme digestion. Sequence variant p.P116L was
analyzed with EagI; p.M145T with BsmAI; p.G159A with
HaeIII; p.R534Q with SfcI, p.R610W with HpaII; p.H746Q
with BsgI, and p.T1110M with NspI. Restriction enzymes were
purchased from Invitrogen or New England Biolabs (Beverly,
MA), and were used according to the recommendations of the
manufacturers.
RESULTS
Characterization of the CRB2 gene and analysis of its ex-
pression pattern: Web based database searches with the 37
amino acid C-terminal cytoplasmic domains of Drosophila
Crumbs and human CRB1 identified two possible homologs
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Figure 2. Expression of CRB1 and CRB2 in human tissues and RPE
cell line ARPE-19.  The expression patterns of CRB1 and CRB2 were
analyzed by RT-PCR on RNA samples of eleven human tissues and
RPE cell line ARPE-19. CRB1 is expressed specifically in retina,
brain, and fetal (fet.) eye. CRB2 is expressed in kidney, fetal eye,
ARPE-19, RPE/choroid, retina, and brain; it is expressed weakly in
lung, placenta, and heart. GAPDH serves as a control. (Skeletal is
abbreviated “sk.”.)
Figure 3. Expression of Crb2 mRNA in the adult mouse eye.  A: The
cellular expression of the Crb2 gene in the adult mouse eye was ana-
lyzed by mRNA in situ hybridizations. Crb2 is expressed in both the
outer nuclear layer (ONL; photoreceptor cells) and inner nuclear layer
(INL; horizontal, amacrine, and bipolar cells). The ganglion cell layer
(GC), inner plexiform layer (IPL), and outer segments (OS) are la-
beled. The OPL collapses as an artifact of fixation/sectioning, but
can be seen as a dark line between the INL and ONL. B: In some
sections, Crb2 expression is also detected in some cells of the gan-
glion cell layer. These may represent displaced amacrine cells. C:
Negative control experiment of the same retina.
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TABLE 4. SEQUENCE VARIANTS DETECTED IN THE CRB2 GENE
                Nucleotide   Amino acid   RP alleles   LCA alleles
    Location      change       change      (n=170)       (n=158)
    ---------   ----------   ----------   ----------   -----------
Amino acid substitutions
    exon 2      137C>T         P46L            0            1
    exon 2      289G>C         V97L            0            1
    exon 2      347C>T         P116L           0            1
    exon 3      434T>C         M145T          60           44
    exon 3      476G>C         G159A          60           41
    exon 3      561G>C         E187D           0            1
    exon 6      1051G>A        A351T           1            0
    exon 7      1601G>A        R534Q           1            0
    exon 7      1828C>T        R610W           0            2
    exon 8      2238C>G        H746Q           1            0
    exon 10     3329C>T        T1110M         12
Synonymous codon changes
    exon 1      61C>T          L21L            2            2
    exon 2      315C>T         C105C           1            0
    exon 3      465C>T         C155C           0            1
    exon 3      516C>T         C172C           0            1
    exon 6      993C>T         N331N
    exon 7      1428T>G        T476T           0            2
    exon 7      1587G>A        A529A          46           57
    exon 7      1920C>T        C640C           8            5
    exon 8      2076C>T        S692S          49           57
    exon 8      2130G>A        P710P           1            0
    exon 9      2523G>A        T841T
    exon 10     2748C>T        A916A           1            0
    exon 10     3021T>C        A1007A         11            9
    exon 10     3126G>C        A1042A                      13
Variations in UTRs and introns
    5' UTR      -16_-22del                   113           78
    intron 2    419-24C>G                      0            1
    intron 3    614+13C>T                      1            1
    intron 3    614+23G>A                      1            0
    intron 4    754+9G>A                       1            0
    intron 4    754+34G>C                     45
    intron 6    1054+15G>A                     0            1
    intron 6    1055-58T>C                    51           61
    intron 9    2603-35C>T                     2            0
    intron 10   3390-60C>T                     0            1
    intron 11   3507-14C>A                     1            2
    intron 12   3633+14G>A                     1            0
    intron 12   3633+17G>T                     1            0
    intron 12   3634-52G>A
Mutation analysis of the CRB2 open reading frame and splice junctions in 85 RP patients and 79 LCA patients revealed 11 amino acid
substitutions, 14 synonymous codon changes, and 14 sequence variants in the untranslated regions and introns. Numbering is based on
GenBank entry AY720432.
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on chromosomes 9q33.3 and 19p13.3. The identification of
the Crumbs homolog 3 (CRB3) gene on 19p13.3 was recently
described [13]. Gene predictions of the Crumbs homolog 2
(CRB2) gene on 9q33.3 were verified by RT-PCR on human
retina cDNA. The CRB2 gene consists of 13 exons, encoding
a 1285 amino acid transmembrane protein. CRB2 has a simi-
lar protein structure as CRB1, characterized by a signal pep-
tide, three laminin A globular (G)-like domains flanked by
epidermal growth factor (EGF)-like domains, a transmembrane
domain, and a 37 amino acid cytoplasmic domain (Figure 1A).
Laminin A G-like domains and EGF-like domains are ex-
tracellular protein modules that can interact with extracellular
proteins and components of the extracellular matrix [27-30].
Laminin A G-like domains consist of 158-180 amino acid resi-
dues, exhibit low overall homology, but have some residues
that are highly conserved [31]. EGF-like domains typically
consist of six cysteine residues that interact with each other
by the formation of disulfide bridges. These stabilize the na-
tive fold, which comprises a major and minor β-sheet. Disul-
fide bridges are formed between the first and third cysteine
residues, the second, and fourth residues, and the fifth and
sixth residues [32]. The CRB2 protein contains 17 EGF-like
domains, however the first and thirteenth EGF-like domains
are truncated, since they contain only 4 cysteine residues (Fig-
ure 1A). A distinct subgroup of EGF-like domains has been
identified that contains a consensus sequence associated with
calcium binding (cb) [33]. In other proteins that contain
tandemly repeated cbEGF domains, such as fibrillin-1, Ca2+ is
predicted to rigidify the interdomain region resulting in a rod-
like structure [34]. In CRB2, EGF-like domains 3-9 contain a
calcium binding sequence (Figure 1A).
The C-terminal cytoplasmic domains of Crumbs, CRB1,
CRB2, and CRB3 are highly conserved (Figure 1B). The cy-
toplasmic domain of CRB2 is 68% identical to that of Droso-
phila Crumbs, 49% identical to CRB1, and 59% identical to
CRB3. This domain is of crucial importance, since it has been
shown to link Crumbs homologs to several cytoplasmic pro-
teins [12,35-42].
The expression pattern of the CRB2 gene was determined
by RT-PCR on RNA samples from 11 human tissues and RPE
cell line ARPE-19. CRB1 and CRB2 are both expressed in
retina, fetal eye and brain. However, CRB2 is also expressed
in kidney, ARPE-19, RPE/choroid, and at low levels in lung,
placenta, and heart (Figure 2). The cellular expression of the
Crb2 gene in the adult mouse eye was analyzed by mRNA in
situ hybridizations. Crb2 is strongly expressed in the outer
nuclear layer, containing the cell bodies of the photoreceptor
cells, and in the inner nuclear layer, containing the cell bodies
of the horizontal, bipolar, amacrine, and Müller glial cells (Fig-
ure 3A). Furthermore, some cells in the ganglion cell layer
also express Crb2 (Figure 3B). The number of cells stained in
the ganglion cell layer varies throughout the retina, suggest-
ing that this particular subset of cells may be displaced ama-
crine cells rather than ganglion cells.
Mutation analysis of the CRB2 gene in patients with re-
tinitis pigmentosa and Leber congenital amaurosis: Mutation
analysis of the CRB2 ORF and splice junctions in 85 RP pa-
tients and 79 LCA patients revealed 14 sequence variants in
the untranslated regions and introns, 14 synonymous codon
changes, and 11 amino acid substitutions (Table 4). To deter-
mine whether the amino acid substitutions are pathogenic, their
frequency was analyzed in control individuals (Table 5). In
addition, we determined whether these amino acid changes
are conservative or nonconservative with respect to charge,
size, and polarity [43], the likelihood that the amino acids in-
volved are replaced during evolution (Blosum62 score) [44],
and whether they are conserved in homologous domains of
Crumbs, CRB1, and CRB2 (Table 5). The amino acid substi-
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TABLE 5. AMINO ACID SUBSTITUTIONS DETECTED IN THE CRB2 GENE
Amino
 acid    Protein   Control       Nature of        Blosum   Conserved
change   domain    alleles      substitution      score     residue
------   -------   -------   ------------------   ------   ---------
P46L      EGF1               nonconservative        -3        Yes
V97L      EGF2      0/372    aliphatic               1        No
P116L     EGF3      0/352    nonconservative        -3        Yes
M145T     EGF3     62/160    nonconservative        -1        Yes
G159A     EGF4     60/160    small hydrophobic       0        Yes
E187D     EGF5      0/346    neg. charged polar      2        Yes
A351T     EGF8               nonconservative         0        No
R534Q     G1        0/356    nonconservative         1        No
R610W     EGF11     2/330    nonconservative        -3        No
H746Q     G2        3/344    nonconservative         0        No
T1110M    EGF15    36/346    nonconservative        -1        No
Eleven amino acid subsitutions were identified by mutation analysis of 85 RP patients and 79 LCA patients. The frequency of these substitu-
tions was analyzed in control individuals. In addition, we determined whether these amino acid changes are conservative or nonconservative
with respect to charge, size, and polarity, the likelihood that the amino acids are replaced during evolution (Blosum62 score), and whether they
are conserved in homologous domains of Crumbs, CRB1 and CRB2. Numbering is based on GenBank entry AY720432.
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tutions p.M145T, p.G159A, and p.T1110M are common poly-
morphisms, since they were found frequently on alleles of RP
and LCA patients and control individuals (Table 4 and Table
5). Substitutions p.R610W and p.H746Q do not affect con-
served residues in the CRB2 protein (Table 5), and both amino
acid substitutions were found on 0.5-1% of control alleles
(Table 5). Therefore, it is likely that they represent rare, non-
pathogenic sequence variants.
Four amino acid substitutions, p.V97L, p.P116L,
p.E187D, and p.R534Q were not found on more than 340 con-
trol alleles, and the presence of two amino acid changes, p.P46L
and p.A351T, could not be determined by ARMS (Table 5).
These six sequence variants were all found in different patient
samples; p.P46L, p.V97L, p.P116L, and p.E187D were found
in LCA patients, p.A351T was identified in an isolated RP
patient, and p.R534Q was detected in a patient with autoso-
mal dominant RP. The latter patient, however, appeared to have
a causative mutation in one of the known autosomal dominant
RP genes (A. Bergen, personal communication). To determine
whether the four LCA patients and the isolated RP patient car-
ried a second CRB2 sequence variant on the other allele, all
CRB2 exons and their splice junctions were sequenced in these
patients. No additional sequence changes were identified,
strongly suggesting that CRB2 sequence variants are not as-
sociated with RP or LCA through an autosomal recessive in-
heritance pattern.
The amino acid substitutions p.V97L and p.A351T affect
nonconserved residues in the EGF-like domains (Figure 4 and
Figure 5). Substitution p.V97L is a conservative (aliphatic)
amino acid change, while p.A351T is a nonconservative change
that is likely to occur during evolution (neutral negative
Blosum62 score; Table 5). However, this does not necessarily
rule out pathogenicity, since not all CRB1 mutations affect
conserved residues and not all missense mutations are
nonconservative changes [45].
The amino acid substitutions p.P116L and p.E187D af-
fect conserved residues located in the cbEGF-like domains
(Figure 4). Sequence variant p.P116L is a nonconservative
amino acid substitution changing a proline to an aliphatic
amino acid, and has a Blosum score of -3, which indicates
that proline is not likely to be replaced by leucine during evo-
lution [44]. However, in one of 30 cbEGF-like domains of
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Dm CRB EGF4      386   DTDECASQ--PCQNNGSCID--------------------------RINGFSCDCSGT-----GYTGAFCQT
Dm CRB EGF5      425   NVDECDKN--PCLNGGRCFDTYG--------------------------WYTCQCLDG------WGGEICDR
Dm CRB EGF11     646   DVDECTLHPKIC-GNGICKNEKG--------------------------SYKCYCTPG------FTGVHCDS
Dm CRB EGF12     685   DVDECLSF--PCLNGATCHNKIN--------------------------AYECVCQPG------YEGENCEV
Dm CRB EGF13     723   DIDECGSN--PCSNGSTCIDRIN--------------------------NFTCNCIPG------MTGRICDI
Dm CRB EGF14     761   DIDDCVGD--PCLNGGQCID--------------------------QLGGFRCDCSGT-----GYEGENCEL
Dm CRB EGF15     800   NIDECLSN--PCTNGAKCLDRVK--------------------------DYFCDCHNG------YKGKNCEQ
Dm CRB EGF16     838   DINECESN--PCQYNGNCLERSNITLYQMSRITDLPKVFSQPFSFENASGYECVCVP------GIIGKNCEI
Dm CRB EGF17     902   NINECDSN--PCSKHGNCN----------------D----------GIGTYTCECEP------GFEGTHCEI
Dm CRB EGF18     940   NIDECDRYN-PCQRG-TCYDQID--------------------------DYDCDCDAN------YGGKNCSV
Dm CRB EGF24    1794   DIDEC-LNT-ECLNNGTCINQVA--------------------------AFFCQCQPG------FEGQHCEQ
Dm CRB EGF25    1832   NIDECADQ--PCHNGGNCTDLIA--------------------------SYVCDCPED------YMGPQCDV
Dm CRB EGF28    1950   DINECESN--PCQNGGQCKD---------------L-----------VGRYECDCQGT-----GFEGIRCEN
Dm CRB EGF29    1989   DIDECNMEGDYCGGLGRCFNKPG--------------------------SFQCICQKP------YCGAYCNF
Hs CRB1 EGF4     148   DHDECASS--PCQNGAVCQDGID--------------------------GYSCFCVP------GYQGRHCDL
Hs CRB1 EGF5     186   EVDECASD--PCKNEATCLNEIG--------------------------RYTCICPHN------YSGVNCEL
Hs CRB1 EGF6     224   EIDECWSQ--PCLNGATCQDALG--------------------------AYFCDCAP------GFLGDHCEL
Hs CRB1 EGF7     262   NTDECASQ--PCLHGGLCVD--------------------------GENRYSCNCTGS-----GFTGTHCET
Hs CRB1 EGF9     339   DLNECNSN--PCQSNGECVELS--SEKQYGRITGLP----SSFSYHEASGYVCICQP------GFTGIHCEE
Hs CRB1 EGF10    397   DVNECSSN--PCQNGGTCENLPG--------------------------NYTCHCPFDNLSRTFYGGRDCSD
Hs CRB1 EGF16   1177   NIDECFSN--PCIHGN-CSDRVA--------------------------AYHCTCEPG------YTGVNCEV
Hs CRB1 EGF17   1214   DIDNCQSH--QCANGATCISHTN--------------------------GYSCLCFGN------FTGKFCRQ
Hs CRB1 EGF19   1297   DIDECASD--PCVNGGLCQDLLN--------------------------KFQCLCDV------AFAGERCEV
Hs CRB2 EGF3     108   DIDECASR--PCHHGATCRNLAD--------------------------RYECHCPLG------YAGVTCEM
Hs CRB2 EGF4     146   EVDECASA--PCLHGGSCLDGVG--------------------------SFRCVCAP------GYGGTRCQL
Hs CRB2 EGF5     184   DLDECQSQ--PCAHGGTCHD--------------------------LVNGFRCDCAGT-----GYEGTHCER
Hs CRB2 EGF6     223   EVLECASA--PCEHNASCLEGLG--------------------------SFRCLCWP------GYSGELCEV
Hs CRB2 EGF7     261   DEDECASS--PCQHGGRCLQRSDPALYGGVQAAFPG-----AFSFRHAAGFLCHCPP------GFEGADCGV
Hs CRB2 EGF8     320   EVDECASR--PCLNGGHCQDLPN--------------------------GFQCHCPD------GYAGPTCEE
Hs CRB2 EGF9     358   DVDECLSD--PCLHGGTCSDTVA--------------------------GYICRCPET------WGGRDCSV
                          |      |    |                                                 |     |
                         E187    |  G159A                                             A351T   |
                               P116L                                                        M145T
Figure 4. Alignment of cbEGF-like domains.  Alignment of the cbEGF-like domains of Drosophila (Dm) Crumbs (CRB; M33753), human
(Hs) CRB1 (AY043325), and human (Hs) CRB2 (AY720432). Amino acid substitutions identified in the cbEGF-like domains of CRB2 in RP
and LCA patients are indicated under the alignment. Identical amino acids are indicated in red and conserved residues in blue. Components of
each line: organism, protein name, number of EGF-like domain, N-terminal amino acid position of the EGF-like domain, amino acid sequence
of the EGF-like domain.
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Crumbs, CRB1 and CRB2, this residue is also aliphatic (iso-
leucine, Figure 4). The substitution p.E187D is a conservative
amino acid change, since both glutamic acid and aspartic acid
are negatively charged polar residues. In one of 30 cbEGF-
like domains of Crumbs, CRB1 and CRB2, this residue is an
aspartic acid (Figure 4). Substitution p.P46L changes an amino
acid that is conserved in the non-cbEGF-like domains, and is
located at a similar position as p.P116L. In one of 36 non-
cbEGF-like domains of Crumbs, CRB1 and CRB2, this resi-
due is a leucine (Figure 5). Based on these findings pathoge-
nicity of the amino acid changes p.E187D, p.P116L, and
p.P46L is not very likely, but cannot completely be ruled out.
DISCUSSION
 Humans have three homologs of Drosophila Crumbs, CRB1
on 1q31.3, CRB2 on 9q33.3, and CRB3 on 19p13.3. The pro-
tein structures of Crumbs, CRB1, and CRB2 are highly simi-
lar, characterized by a large extracellular domain consisting
of laminin A G-like domains flanked by EGF-like domains,
and a 37 amino acid cytoplasmic domain. CRB3 encodes a
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Dm CRB EGF1     267    -----NFC---LND-PCMGHGTCS-----SSPE--GYECRCTARYSGKNCQKDN
Dm CRB EGF2     305    ----GSPC---AKN-PCENGGSCLE----NSRG--DYQCFCDPNHSGQHCETEV
Dm CRB EGF3     345    --NIHPLC---QTN-PCLNNGACV-----VIGGSGALTCECPKGYAGARCEV--
Dm CRB EGF6     464    -----MTC---QTQ-QCLNGGTCL-----DKPI--GFQCLCPPEYTGELCQIA-
Dm CRB EGF7     501    -----PSC-----AQQCPIDSECVGGKCVCKPGSSGYNCQTSTGDGASALALTP
Dm CRB EGF8     545    -----INCN--ATNGKCLNGGTCS------MNG---THCYCAVGYSGDRCEKA-
Dm CRB EGF9     582    -----ENCS--PLN--CQEPMVCV-----------QNQCLCPE---NKVCNQ--
Dm CRB EGF10    611    -------C---ATQ-PCQNGGECVD----LPNG--DYECKCTRGWTGRTCGN--
Dm CRB EGF19    979    ----LKGC---DQN-PCLNGGACLPYLINEVTH--LYNCTCENGFQGDKCEKT-
Dm CRB EGF20   1207    -----EQC---KPN-PCHSNGECT-----DLWH--TFACHCPRPFFGHTCQHN-
Dm CRB EGF21   1480    ----DDLC---RKN-PCLHNAECR-----NTWN--DYTCKCPNGYKGKNCQ---
Dm CRB EGF22   1516    ---EIEFC----QHVTCPGQSLCQN---LD-DG---YECVTN------------
Dm CRB EGF23   1759    ------LC---FQS-DCKNDGFCQ-----SPSD--EYACTCQPGFEGDDCGT--
Dm CRB EGF26   1872    ----QMTC---ENE-PCRNGSTCQNGFNASTGN--NFTCTCVPGFEGPLCD---
Dm CRB EGF27   1913    ----IPFC---EIT-PCDNGGLCL-----TTGA--VPMCKCSLGYTGRLCEQ--
Dm CRB EGF30   2030    -----DPCN--ATD-LCSNGGRCVE----SCGAKPDYYCECPEGFAGKNCTAP-
Hs CRB1 EGF1     30    ---NNTRC---LSN-SCQNNSTCK----DFSKD-NDCSCSDTANNLDKDCDN--
Hs CRB1 EGF2     70    ---MKDPC---FSN-PCQGSATCV-----NTPGERSFLCKCPPGYSGTICET--
Hs CRB1 EGF3    110    ---TIGSC---GKN-SCQHGGICH-------QDPIYPVCICPAGYAGRFCEI--
Hs CRB1 EGF8    301    ---LMPLC---WSK-PCHNNATCE-----DSVD--NYTCHCWPGYTGAQCEI--
Hs CRB1 EGF11   441    ---ILLGC---THQ-QCLNNGTCIPHFQ-DGQH--GFSCLCPSGYTGSLCEI--
Hs CRB1 EGF12   672    ---RKDWC---ESQ-PCQSRGRCI-----NLWL--SYQCDCHRPYEGPNCLR--
Hs CRB1 EGF13   887    ---GDNSC---KSN-PCHNGGVCH-----SRWD--DFSCSCPALTSGKACEE--
Hs CRB1 EGF14   925    ----VQWC---GFS-PCPHGAQCQP----VLQG---FECIANAVFNG-------
Hs CRB1 EGF15  1139    ---QLNVC---NSN-PCLHGGNCE-----DIYS--SYHCSCPLGWSGKHCEL--
Hs CRB1 EGF18  1252    SRLPSTVCGNEKTNLTCYNGGNCT-----EFQT--ELKCMCRPGFTGEWCEK--
Hs CRB2 EGF1     38    ---PPSAC---ASD-PCAPGTECQA----TESG--GYTCGPM------------
Hs CRB2 EGF2     67    ---EPRGC---ATQ-PCHHGALCVP----QGPDPTGFRCYCVPGFQGPRCEL--
Hs CRB2 EGF10   396    ---QLTGC---QGH-TCPLAATCIP---IFESGVHSYVCHCPPGTHGPFCGQ--
Hs CRB2 EGF11   605    ---RREQC---RPL-PCVHGGSCV-----DLWT--HFRCDCARPHRGPTCAD--
Hs CRB2 EGF12   807    ---SEDMC---SPD-PCFNGGTC---L--VTWN--DFHCTCPANFTGPTCAQ--
Hs CRB2 EGF13   845    ----QLWC---PGQ-PCLPPATCE----EVPDG---FVCVAEATFRE-------
Hs CRB2 EGF14  1056    ---GAPVC---APS-PCLHDGACR-----DLFD--AFACACGPGWEGPRCEA--
Hs CRB2 EGF15  1094    ---HVDPC---HSA-PCAR-GRCH-----THPD-GRFECRCPPGFGGPRCRL--
Hs CRB2 EGF16  1134    ---PSKECS--LNV-TCLDGSPCE------GGS-PAANCSCLEGLAGQRCQV--
Hs CRB2 EGF17  1173    ---PTLPC---EAN-PCLNGGTCR-----AAGG--VSECICNARFSGQFCEV--
                                  |   |             |           |
                                  |  P46L         T1110M       V97L
                                R610W
Figure 5. Alignment of non-cbEGF-like domains.  Alignment of the non-cbEGF-like domains of Drosophila (Dm) Crumbs (CRB; M33753),
human (Hs) CRB1 (AY043325), and human (Hs) CRB2 (AY720432). Amino acid substitutions identified in the non-cbEGF-like domains of
CRB2 in RP and LCA patients are indicated under the alignment. Identical amino acids are indicated in red and conserved residues in blue.
Components of each line: organism, protein name, number of EGF-like domain, N-terminal amino acid position of the EGF-like domain,
amino acid sequence of the EGF-like domain.
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small protein of 120 amino acids lacking the laminin A G-like
domains and EGF-like domains, but it has a cytoplasmic do-
main that is highly similar to that of Crumbs, CRB1, and CRB2
[13]. The CRB1 gene encodes a transmembrane and an extra-
cellular protein isoform by alternative splicing [1,46]. Gene
predictions suggest that the CRB2 gene may also be alterna-
tively spliced, encoding a transmembrane and an extracellu-
lar protein isoform, but this was not analyzed by RT-PCR [47].
All three Crumbs homologs are expressed in the retina
[1,13,48]. CRB1 expression was found to be restricted to retina
and brain [1,49], although in mouse Crb1 expression was also
detected in kidney, stomach, lung, and testis [50]. However,
CRB2 and CRB3 are expressed in a wider range of tissues. In
this report we showed that CRB2 is expressed in brain, kid-
ney, ARPE-19, RPE/choroid, and at low levels in lung, pla-
centa, and heart. CRB3 is expressed in lung, kidney, colon,
and mammary gland [13]. In mouse retina Crb1 expression is
restricted to the photoreceptors and some cells of the inner
nuclear layer [49], while Crb2 is expressed in all layers of the
retina. In the photoreceptors, the Crb1 protein is confined to
the inner segment, where it concentrates just apical to the outer
limiting membrane (OLM), a region of cell-cell adhesion be-
tween photoreceptors and Müller cells [10]. Recently, it was
shown that Crb2 and Crb3 colocalize with Crb1 at the OLM
[48]. Redundant functions of CRB1, CRB2, and CRB3 are
not known, but their co-localization at the OLM, and the high
similarity of their cytoplasmic domains, suggest a possible
overlap or competition in function [48].
Mutations in the CRB1 gene cause autosomal recessive
RP and LCA [1,5,6]. We screened the CRB2 gene for muta-
tions in patients with RP and LCA and detected 11 amino acid
substitutions. Five of them (p.M145T, p.G159A, p.R610W,
p.H746Q, p.T1110M) were detected in control individuals, and
are therefore likely to be nonpathogenic sequence variants.
One sequence variant, p.R534Q, was detected in a patient with
autosomal dominant RP, but this patient had a causative mu-
tation in a known autosomal dominant RP gene. We did not
detect a second CRB2 sequence variant on the other allele in
the LCA patients and isolated RP patient that carried the re-
maining five amino acid substitutions (p.P46L, p.V97L,
p.P116L, p.E187D, p.A351T), although we may have missed
large deletions or rearrangements. Nevertheless, this renders
autosomal recessive inheritance of CRB2 sequence variants
as a cause of RP and LCA highly unlikely, but does not rule
out digenic or polygenic mechanisms, or a de novo introduc-
tion of a dominant mutation. Interestingly, polygenic inherit-
ance has recently been proposed for LCA [51]. Sequence vari-
ant p.E187D affects a residue that is conserved in the cbEGF-
like domains, and which may provide ligands for binding of
the calcium ion. Introduction of the longer side chain may
affect calcium binding and disrupt the domain structure [34].
It is noteworthy that the same substitution (p.E1073D) at a
similar position in one the cbEGF-like domains of fibrillin-1
results in a connective tissue disease [52].
Although we cannot completely rule out pathogenicity of
some CRB2 sequence variants, this study shows that they are
not a common cause of autosomal recessive RP and LCA.
This study suggests that the CRB2 gene is highly polymor-
phic in comparison to the CRB1 gene [45]. Similarly, a retina
specific paralog of the RP1 gene (RP1L1) is also highly poly-
morphic, and no RP1L1 mutations were detected in patients
with retinal dystrophies [53,54]. It is possible that loss or al-
tered function of CRB2 in humans is associated with a more
complex clinical phenotype due to its expression in kidney.
CRB2 therefore represents a candidate gene for cerebello-
oculo-renal syndromes, such as Joubert syndrome, Dekaba-
Arima syndrome, Senior-Löken syndrome, and COACH syn-
drome. A locus for Joubert syndrome maps to 9q34.3 [55], but
CRB2 does not reside in the critical interval.
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